Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232276 | SCV000290767 | benign | Parathyroid carcinoma | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000267832 | SCV000352119 | likely benign | Hyperparathyroidism 2 with jaw tumors | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000232276 | SCV000352120 | likely benign | Parathyroid carcinoma | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000372976 | SCV000352121 | likely benign | Hyperparathyroidism 1 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000858076 | SCV000530378 | likely benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17130827, 20052758, 12960210, 17065424) |
Ce |
RCV000858076 | SCV001147565 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CDC73: BP4 |
Ambry Genetics | RCV001020200 | SCV001181648 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001020200 | SCV002530567 | benign | Hereditary cancer-predisposing syndrome | 2020-10-16 | criteria provided, single submitter | curation | |
Genome Diagnostics Laboratory, |
RCV001729478 | SCV001977656 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000858076 | SCV001980290 | likely benign | not provided | no assertion criteria provided | clinical testing |